Which has higher earnings & valuation, ECOR or IRIX?

IRIDEX has higher revenue and earnings than electroCore. IRIDEX is trading at a lower price-to-earnings ratio than electroCore, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio electroCore $32.03M 2.57 -$13.97M -$1.77 N/A IRIDEX $52.67M 0.37 -$4.44M -$0.19 N/A

Is ECOR or IRIX more profitable?

IRIDEX has a net margin of -6.23% compared to electroCore's net margin of -44.08%. IRIDEX's return on equity of -1,204.74% beat electroCore's return on equity. Company Net Margins Return on Equity Return on Assets electroCore -44.08% -1,956.38% -83.30% IRIDEX -6.23% -1,204.74% -11.16%

Does the media refer more to ECOR or IRIX?

In the previous week, IRIDEX had 1 more articles in the media than electroCore. MarketBeat recorded 3 mentions for IRIDEX and 2 mentions for electroCore. electroCore's average media sentiment score of 0.94 beat IRIDEX's score of 0.87 indicating that electroCore is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment electroCore 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive IRIDEX 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Do analysts rate QTEX or IRIX?

IRIDEX has a consensus target price of $3.00, indicating a potential upside of 165.49%. Given IRIDEX's stronger consensus rating and higher probable upside, analysts clearly believe IRIDEX is more favorable than Inspira Technologies OXY B.H.N.. Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Inspira Technologies OXY B.H.N. 1 Sell rating(s) 0 Hold rating(s) 0 Buy rating(s) 0 Strong Buy rating(s) 1.00 IRIDEX 1 Sell rating(s) 0 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.00

Which has preferable earnings and valuation, QTEX or IRIX?

IRIDEX has higher revenue and earnings than Inspira Technologies OXY B.H.N.. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio Inspira Technologies OXY B.H.N. $290K 176.03 -$13.22M N/A N/A IRIDEX $52.67M 0.37 -$4.44M -$0.19 N/A

Does the media refer more to QTEX or IRIX?

In the previous week, Inspira Technologies OXY B.H.N. had 1 more articles in the media than IRIDEX. MarketBeat recorded 4 mentions for Inspira Technologies OXY B.H.N. and 3 mentions for IRIDEX. IRIDEX's average media sentiment score of 0.87 beat Inspira Technologies OXY B.H.N.'s score of 0.47 indicating that IRIDEX is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Inspira Technologies OXY B.H.N. 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral IRIDEX 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable earnings and valuation, IRIX or LNSR?

IRIDEX has higher earnings, but lower revenue than LENSAR. LENSAR is trading at a lower price-to-earnings ratio than IRIDEX, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio IRIDEX $52.67M 0.37 -$4.44M -$0.19 N/A LENSAR $58.44M 1.18 -$34.28M -$0.58 N/A

Is IRIX or LNSR more profitable?

LENSAR has a net margin of 50.94% compared to IRIDEX's net margin of -6.23%. LENSAR's return on equity of -183.19% beat IRIDEX's return on equity. Company Net Margins Return on Equity Return on Assets IRIDEX -6.23% -1,204.74% -11.16% LENSAR 50.94% -183.19% 42.26%

Does the media refer more to IRIX or LNSR?

In the previous week, IRIDEX and IRIDEX both had 3 articles in the media. IRIDEX's average media sentiment score of 0.87 beat LENSAR's score of 0.22 indicating that IRIDEX is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment IRIDEX 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive LENSAR 0 Very Positive mention(s) 0 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 1 Very Negative mention(s) Neutral

Which has stronger earnings & valuation, IRIX or LUNG?

IRIDEX has higher earnings, but lower revenue than Pulmonx. IRIDEX is trading at a lower price-to-earnings ratio than Pulmonx, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio IRIDEX $52.67M 0.37 -$4.44M -$0.19 N/A Pulmonx $90.50M 0.67 -$54M -$1.30 N/A

Is IRIX or LUNG more profitable?

IRIDEX has a net margin of -6.23% compared to Pulmonx's net margin of -60.09%. Pulmonx's return on equity of -92.94% beat IRIDEX's return on equity. Company Net Margins Return on Equity Return on Assets IRIDEX -6.23% -1,204.74% -11.16% Pulmonx -60.09% -92.94% -39.80%

Does the media favor IRIX or LUNG?

In the previous week, IRIDEX had 1 more articles in the media than Pulmonx. MarketBeat recorded 3 mentions for IRIDEX and 2 mentions for Pulmonx. IRIDEX's average media sentiment score of 0.87 beat Pulmonx's score of 0.79 indicating that IRIDEX is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment IRIDEX 0 Very Positive mention(s) 1 Positive mention(s) 1 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Pulmonx 0 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 1 Negative mention(s) 0 Very Negative mention(s) Positive

Which has preferable earnings and valuation, IRIX or MDAI?

IRIDEX has higher revenue and earnings than Spectral AI. IRIDEX is trading at a lower price-to-earnings ratio than Spectral AI, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio IRIDEX $52.67M 0.37 -$4.44M -$0.19 N/A Spectral AI $19.65M 2.96 -$7.57M -$0.53 N/A

Is IRIX or MDAI more profitable?

IRIDEX has a net margin of -6.23% compared to Spectral AI's net margin of -85.58%. Spectral AI's return on equity of 0.00% beat IRIDEX's return on equity. Company Net Margins Return on Equity Return on Assets IRIDEX -6.23% -1,204.74% -11.16% Spectral AI -85.58% N/A -72.97%

IRIDEX (IRIX) Competitors

$1.13 +0.01 (+0.89%)

Closing price 04:00 PM Eastern

Extended Trading

$1.13 0.00 (0.00%)

As of 06:43 PM Eastern

Compare

IRIX vs. ECOR, QTEX, LNSR, LUNG, and MDAI

Should you buy IRIDEX stock or one of its competitors? MarketBeat compares IRIDEX with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with IRIDEX include electroCore (ECOR), Inspira Technologies OXY B.H.N. (QTEX), LENSAR (LNSR), Pulmonx (LUNG), and Spectral AI (MDAI). These companies are all part of the "medical equipment" industry.

How does IRIDEX compare to electroCore?

electroCore (NASDAQ:ECOR) and IRIDEX (NASDAQ:IRIX) are both small-cap medical equipment companies, but which is the superior stock? We will compare the two companies based on the strength of their profitability, risk, media sentiment, valuation, earnings, institutional ownership, analyst recommendations and dividends.

26.7% of electroCore shares are held by institutional investors. Comparatively, 20.1% of IRIDEX shares are held by institutional investors. 13.8% of electroCore shares are held by insiders. Comparatively, 8.6% of IRIDEX shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.

electroCore currently has a consensus price target of $18.00, indicating a potential upside of 81.27%. IRIDEX has a consensus price target of $3.00, indicating a potential upside of 165.49%. Given IRIDEX's higher possible upside, analysts plainly believe IRIDEX is more favorable than electroCore.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
electroCore	1 Sell rating(s)	1 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
IRIDEX	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

IRIDEX has higher revenue and earnings than electroCore. IRIDEX is trading at a lower price-to-earnings ratio than electroCore, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
electroCore	$32.03M	2.57	-$13.97M	-$1.77	N/A
IRIDEX	$52.67M	0.37	-$4.44M	-$0.19	N/A

IRIDEX has a net margin of -6.23% compared to electroCore's net margin of -44.08%. IRIDEX's return on equity of -1,204.74% beat electroCore's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
electroCore	-44.08%	-1,956.38%	-83.30%
IRIDEX	-6.23%	-1,204.74%	-11.16%

electroCore has a beta of 0.83, meaning that its stock price is 17% less volatile than the broader market. Comparatively, IRIDEX has a beta of 0.64, meaning that its stock price is 36% less volatile than the broader market.

In the previous week, IRIDEX had 1 more articles in the media than electroCore. MarketBeat recorded 3 mentions for IRIDEX and 2 mentions for electroCore. electroCore's average media sentiment score of 0.94 beat IRIDEX's score of 0.87 indicating that electroCore is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
electroCore	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
IRIDEX	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

IRIDEX beats electroCore on 8 of the 14 factors compared between the two stocks.

How does IRIDEX compare to Inspira Technologies OXY B.H.N.?

Inspira Technologies OXY B.H.N. (NASDAQ:QTEX) and IRIDEX (NASDAQ:IRIX) are both small-cap medical equipment companies, but which is the better business? We will contrast the two businesses based on the strength of their profitability, risk, dividends, earnings, institutional ownership, analyst recommendations, valuation and media sentiment.

Inspira Technologies OXY B.H.N. has a beta of 4.11, meaning that its share price is 311% more volatile than the broader market. Comparatively, IRIDEX has a beta of 0.64, meaning that its share price is 36% less volatile than the broader market.

In the previous week, Inspira Technologies OXY B.H.N. had 1 more articles in the media than IRIDEX. MarketBeat recorded 4 mentions for Inspira Technologies OXY B.H.N. and 3 mentions for IRIDEX. IRIDEX's average media sentiment score of 0.87 beat Inspira Technologies OXY B.H.N.'s score of 0.47 indicating that IRIDEX is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Inspira Technologies OXY B.H.N.	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
IRIDEX	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

IRIDEX has a consensus target price of $3.00, indicating a potential upside of 165.49%. Given IRIDEX's stronger consensus rating and higher probable upside, analysts clearly believe IRIDEX is more favorable than Inspira Technologies OXY B.H.N..

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Inspira Technologies OXY B.H.N.	1 Sell rating(s)	0 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.00
IRIDEX	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

12.7% of Inspira Technologies OXY B.H.N. shares are held by institutional investors. Comparatively, 20.1% of IRIDEX shares are held by institutional investors. 29.4% of Inspira Technologies OXY B.H.N. shares are held by insiders. Comparatively, 8.6% of IRIDEX shares are held by insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a company is poised for long-term growth.

IRIDEX has higher revenue and earnings than Inspira Technologies OXY B.H.N..

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Inspira Technologies OXY B.H.N.	$290K	176.03	-$13.22M	N/A	N/A
IRIDEX	$52.67M	0.37	-$4.44M	-$0.19	N/A

Inspira Technologies OXY B.H.N. has a net margin of 0.00% compared to IRIDEX's net margin of -6.23%. Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat IRIDEX's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Inspira Technologies OXY B.H.N.	N/A	N/A	N/A
IRIDEX	-6.23%	-1,204.74%	-11.16%

Summary

Inspira Technologies OXY B.H.N. and IRIDEX tied by winning 7 of the 14 factors compared between the two stocks.

How does IRIDEX compare to LENSAR?

IRIDEX (NASDAQ:IRIX) and LENSAR (NASDAQ:LNSR) are both small-cap medical equipment companies, but which is the superior business? We will contrast the two businesses based on the strength of their analyst recommendations, earnings, institutional ownership, media sentiment, valuation, dividends, risk and profitability.

20.1% of IRIDEX shares are owned by institutional investors. Comparatively, 40.2% of LENSAR shares are owned by institutional investors. 8.6% of IRIDEX shares are owned by insiders. Comparatively, 66.0% of LENSAR shares are owned by insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company is poised for long-term growth.

IRIDEX has a beta of 0.64, indicating that its stock price is 36% less volatile than the broader market. Comparatively, LENSAR has a beta of 0.87, indicating that its stock price is 13% less volatile than the broader market.

In the previous week, IRIDEX and IRIDEX both had 3 articles in the media. IRIDEX's average media sentiment score of 0.87 beat LENSAR's score of 0.22 indicating that IRIDEX is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
IRIDEX	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
LENSAR	0 Very Positive mention(s)	0 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	1 Very Negative mention(s)	Neutral

IRIDEX currently has a consensus target price of $3.00, suggesting a potential upside of 165.49%. LENSAR has a consensus target price of $10.00, suggesting a potential upside of 76.06%. Given IRIDEX's higher possible upside, equities research analysts plainly believe IRIDEX is more favorable than LENSAR.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IRIDEX	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
LENSAR	1 Sell rating(s)	0 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	2.33

IRIDEX has higher earnings, but lower revenue than LENSAR. LENSAR is trading at a lower price-to-earnings ratio than IRIDEX, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IRIDEX	$52.67M	0.37	-$4.44M	-$0.19	N/A
LENSAR	$58.44M	1.18	-$34.28M	-$0.58	N/A

LENSAR has a net margin of 50.94% compared to IRIDEX's net margin of -6.23%. LENSAR's return on equity of -183.19% beat IRIDEX's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IRIDEX	-6.23%	-1,204.74%	-11.16%
LENSAR	50.94%	-183.19%	42.26%

Summary

LENSAR beats IRIDEX on 10 of the 15 factors compared between the two stocks.

How does IRIDEX compare to Pulmonx?

IRIDEX (NASDAQ:IRIX) and Pulmonx (NASDAQ:LUNG) are both small-cap medical equipment companies, but which is the superior investment? We will contrast the two businesses based on the strength of their dividends, risk, analyst recommendations, earnings, profitability, media sentiment, institutional ownership and valuation.

IRIDEX presently has a consensus price target of $3.00, indicating a potential upside of 165.49%. Pulmonx has a consensus price target of $5.58, indicating a potential upside of 290.44%. Given Pulmonx's stronger consensus rating and higher probable upside, analysts plainly believe Pulmonx is more favorable than IRIDEX.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IRIDEX	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Pulmonx	1 Sell rating(s)	2 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.43

20.1% of IRIDEX shares are owned by institutional investors. Comparatively, 91.0% of Pulmonx shares are owned by institutional investors. 8.6% of IRIDEX shares are owned by company insiders. Comparatively, 6.8% of Pulmonx shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

IRIDEX has a net margin of -6.23% compared to Pulmonx's net margin of -60.09%. Pulmonx's return on equity of -92.94% beat IRIDEX's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IRIDEX	-6.23%	-1,204.74%	-11.16%
Pulmonx	-60.09%	-92.94%	-39.80%

IRIDEX has a beta of 0.64, suggesting that its stock price is 36% less volatile than the broader market. Comparatively, Pulmonx has a beta of 0.28, suggesting that its stock price is 72% less volatile than the broader market.

In the previous week, IRIDEX had 1 more articles in the media than Pulmonx. MarketBeat recorded 3 mentions for IRIDEX and 2 mentions for Pulmonx. IRIDEX's average media sentiment score of 0.87 beat Pulmonx's score of 0.79 indicating that IRIDEX is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
IRIDEX	0 Very Positive mention(s)	1 Positive mention(s)	1 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Pulmonx	0 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	1 Negative mention(s)	0 Very Negative mention(s)	Positive

IRIDEX has higher earnings, but lower revenue than Pulmonx. IRIDEX is trading at a lower price-to-earnings ratio than Pulmonx, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IRIDEX	$52.67M	0.37	-$4.44M	-$0.19	N/A
Pulmonx	$90.50M	0.67	-$54M	-$1.30	N/A

Summary

IRIDEX and Pulmonx tied by winning 8 of the 16 factors compared between the two stocks.

How does IRIDEX compare to Spectral AI?

IRIDEX (NASDAQ:IRIX) and Spectral AI (NASDAQ:MDAI) are both small-cap medical equipment companies, but which is the superior stock? We will compare the two companies based on the strength of their earnings, institutional ownership, risk, analyst recommendations, valuation, dividends, profitability and media sentiment.

IRIDEX has higher revenue and earnings than Spectral AI. IRIDEX is trading at a lower price-to-earnings ratio than Spectral AI, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
IRIDEX	$52.67M	0.37	-$4.44M	-$0.19	N/A
Spectral AI	$19.65M	2.96	-$7.57M	-$0.53	N/A

IRIDEX has a net margin of -6.23% compared to Spectral AI's net margin of -85.58%. Spectral AI's return on equity of 0.00% beat IRIDEX's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
IRIDEX	-6.23%	-1,204.74%	-11.16%
Spectral AI	-85.58%	N/A	-72.97%

In the previous week, IRIDEX had 2 more articles in the media than Spectral AI. MarketBeat recorded 3 mentions for IRIDEX and 1 mentions for Spectral AI. Spectral AI's average media sentiment score of 1.87 beat IRIDEX's score of 0.87 indicating that Spectral AI is being referred to more favorably in the news media.

Company	Overall Sentiment
IRIDEX	Positive
Spectral AI	Very Positive

IRIDEX has a beta of 0.64, indicating that its share price is 36% less volatile than the broader market. Comparatively, Spectral AI has a beta of 1.15, indicating that its share price is 15% more volatile than the broader market.

IRIDEX presently has a consensus target price of $3.00, indicating a potential upside of 165.49%. Spectral AI has a consensus target price of $4.00, indicating a potential upside of 118.58%. Given IRIDEX's higher possible upside, equities research analysts plainly believe IRIDEX is more favorable than Spectral AI.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
IRIDEX	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00
Spectral AI	1 Sell rating(s)	0 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.00

20.1% of IRIDEX shares are owned by institutional investors. Comparatively, 67.1% of Spectral AI shares are owned by institutional investors. 8.6% of IRIDEX shares are owned by insiders. Comparatively, 13.7% of Spectral AI shares are owned by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock will outperform the market over the long term.

Summary

IRIDEX and Spectral AI tied by winning 7 of the 14 factors compared between the two stocks.

Get IRIDEX News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IRIX and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

IRIX vs. The Competition

Export

Metric	IRIDEX	LASERS Industry	Computer Sector	NASDAQ Exchange
Market Cap	$19.50M	$833.53M	$38.79B	$11.95B
Dividend Yield	N/A	N/A	3.15%	5.61%
P/E Ratio	-5.95	37.71	169.67	23.63
Price / Sales	0.37	162.60	629.16	103.49
Price / Cash	N/A	39.71	47.72	54.72
Price / Book	-18.83	17.52	9.46	6.70
Net Income	-$4.44M	-$16.97M	$1.07B	$337.26M
7 Day Performance	-2.16%	-7.39%	-3.27%	-1.41%
1 Month Performance	9.71%	-5.31%	2.87%	1.15%
1 Year Performance	19.58%	-8.19%	153.02%	22.61%

IRIDEX Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
IRIX IRIDEX	2.3745 of 5 stars	$1.13 +0.9%	$3.00 +165.5%	+13.5%	$19.50M	$52.67M	N/A	120	News Coverage Gap Up
ECOR electroCore	3.4762 of 5 stars	$9.63 +1.9%	$18.00 +86.9%	+70.6%	$79.93M	$32.03M	N/A	50
QTEX Inspira Technologies OXY B.H.N.	0.3181 of 5 stars	$2.09 -9.9%	N/A	N/A	$75.14M	$290K	N/A	20	News Coverage Short Interest Increase Gap Down
LNSR LENSAR	2.3558 of 5 stars	$5.64 -1.7%	$10.00 +77.3%	-56.5%	$68.24M	$58.44M	N/A	110	News Coverage
LUNG Pulmonx	2.0001 of 5 stars	$1.56 -3.1%	$5.58 +257.9%	-55.0%	$65.89M	$90.50M	N/A	250

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:IRIX) was last updated on 6/10/2026 by MarketBeat.com Staff.

From Our Partners

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

IRIDEX (IRIX) Competitors